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Objectives: Perioperative risk associated with pulmonary hypertension (PH) in patients under-
going non-cardiac surgery (NCS) remains poorly defined. We report perioperative outcomes in
a large cohort of patients undergoing NCS, comparing those with and without PH.
Methods: Patients undergoing NCS at our institution between January 2002 and December
2006, were cross matched with a Right Heart Catheterization (RHC) database for the same
period. Patients were excluded if they were <18 years old and if they underwent cardiac
surgery prior to NCS or minor procedures using local anesthesia or sedation. Controls were
defined as patients who underwent similar NCS with mean pulmonary arterial pressure
(MPAP)  25 mmHg.
Results: 173 patients underwent RHC and NCS during the specified period and were included in
the analysis. Of these 96 (55%) had PH. Mean pulmonary arterial pressure (p Z 0.001), Amer-
ican Association of Anesthesiology Class (pZ 0.02), and chronic renal insufficiency (pZ 0.03)
were determined as independent risk factors for post-operative morbidity. Patients with PHts of Hospital Medicine (Medicine Institute) and Outcomes Research (Anesthesiology Institute),
dicine, Desk A13, 9500 Euclid Avenue, Cleveland OH 44195, United States. Tel.: þ1 216 444 5633;
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620 R. Kaw et al.were more likely to develop congestive heart failure (p < 0.001; OR: 11.9), hemodynamic
instability (p < 0.002), sepsis (p < 0.0005), and respiratory failure (p < 0.004). Patients with
PH needed longer ventilatory support (p < 0.002), stayed longer in the ICU (p < 0.04), and
were more frequently readmitted to the hospital within 30 days (p < 008; OR 2.4).
Conclusions: In addition to the traditionally known risk factors for outcomes after NCS such as
coronary artery disease, diabetes mellitus, chronic renal insufficiency, American Society of
Anesthesiology class, the presence of underlying PH can have a significant negative impact
on perioperative outcomes.
ª 2010 Elsevier Ltd. All rights reserved.Background
Pulmonary hypertension (PH) is defined as mean pulmonary
arterial pressure (MPAP) > 25mmHg at rest or >30 mmHg
during exercise.1 The adverse impact of PH on cardiac
surgical outcomes is well known from several studies.2,3 PH
after cardiopulmonary bypass has been reported to have
mortality rates upto 25%.4 Preoperative MPAP > 30 mmHg
has been shown to be a significant independent predictor of
post-operative mortality in over 2000 patients undergoing
cardiopulmonary bypass.4 In view of this, patients under-
going cardiac surgery are usually evaluated for the etiology
and severity of PH.
PH is also understood to be a major contributor to post-
operative morbidity and mortality after heart and lung
transplantation,5,6 liver transplantation,7e10 and pneumo-
nectomy. However, most of the literature is based on case
reports and series and perioperative risk factors in patients
with PH undergoing non-cardiac surgery (NCS) remain poorly
defined.11e13 PH is currently not classified as an independent
risk factor for post-operative complications after NCS.14
Patients with PH are living longer, due to a wide variety of
new and effective therapeutic options and may require an
elective NCS procedure at some point in their life. Physicians
may counsel against such procedures given the scarcity of
evidence based till recently on isolated case series.15e18 The
aims of our study were to evaluate the perioperative
outcomes in patients with and without PH after NCS and to
identify hemodynamic factors associated with these adverse
outcomes.
Materials and methods
Study population
The study population was chosen from over 5445 patients
who underwent pulmonary artery catheterization (PAC) at
a major tertiary care center between January 2002 and
December 2006. This electronic record was cross-referenced
with IMPACT (Internal Medicine Preoperative Assessment
Consultation and Treatment) data that included patients who
underwent preoperative evaluation prior to NCS during the
specified period. All patients undergoing NCS procedure
within2years ofPACwere included in theanalysis. All patients
under the age of 18, those who underwent cardiac surgery,
surgery or procedures under local anesthesia and intravenous
sedation, and patients with a pre-existing tracheostomy were
excluded. Demographic, clinical, diagnostic, and post-oper-
ative datawere collected fromoutpatient electronic records,inpatient hospital admission records, and surgical procedure
dictation records. Patients with PH (defined as
MPAP > 25 mmHg) were subdivided into 3 categories: 1)
pulmonary arterial hypertension (PAH) as defined by
a pulmonary capillary wedge pressure (PCWP)< 15 mmHg; 2)
pulmonary venous hypertension (PVH) as defined by
a PCWP  15 mmHg and pulmonary vascular resistance
(PVR) < 3 Wood units; and 3) ‘mixed’ PH as defined by PCWP
>15 and PVR 3 Wood units.
Preoperative morbidity data collection
Preoperative morbidity data and post-operative outcomes
were collected for the NCS procedure in closest approxima-
tion to the date of PAC. Major co-morbid conditions were
defined according to Hosking et al.19 In case a patient
underwent more than one PAC procedure within the specified
time period, the one with more adverse hemodynamic values
of MPAP, was chosen for data collection. Transthoracic echo-
cardiographic data closest to the date of surgery was used.
The study protocol was approved by our Institutional Review
Board. The approval included a waiver of informed consent.
Postoperative morbidity definitions
The clinical outcome endpoints for this studywere significant
post-operative complications including: congestive heart
failure (CHF), myocardial infarction (MI), respiratory failure
(RF), hemodynamic instability (HDI), sepsis, death within 30
days, hospital length of stay, and 30 day readmission. These
data were obtained from electronic medical records, oper-
ative notes, post-anesthetic care unit records and discharge
summary notes. perioperative CHF was defined as new
pulmonary edema, elevated JVP > 10 mmHg, use of diuretic
or afterload/preload reducing agents, or physician docu-
mentation of CHF. Perioperative RF was defined as need for
prolonged mechanical ventilation (>24 h), need for reintu-
bation, or tracheostomy. Perioperative MI was defined as
appearance of new Q waves >0.04 s wide and 1 mV in depth
accompanied by elevated levels of troponin T (>0.03 ng/ml)
and creatine kinase-MB (>100 IU/l). HDI was defined by the
need for inotropic or vasopressor support. Hospital read-
missions were likely an underestimate since only patients
readmitted to our institution could be identified.
Statistical analysis
Data analysis was performed in two ways. First the overall
group undergoing NCS was analyzed to identify adverse
IMPACT* Registry
n = 60,000
Patients who underwent both
Non-Cardiac Surgery (NCS) and 
Right Heart Catheterization (RHC)
n = 526
CCF RHC** Registry 
n = 5445
I/E Criteria (list)#
n = 173
Patients with PH who 
underwent NCS
(n = 96)
Patients without PH who 
underwent NCS
(n = 77)
Figure 1 Flow diagram of patient selection for the study.
Pulmonary hypertensionoutcomes and risk factors independently associated with
these outcomes. Subsequently, patients were divided into
two groups to compare the outcomes between patients
with and without PH. Univariate associations with mortality
and morbidity were analyzed with chi-square tests or log-
istic regression. The final multivariate logistic model was
developed by including demographic, clinical, and diag-
nostic variables and sequentially eliminating the preoper-
ative, demographic, clinical, and diagnostic variables that
were not significant (p > 0.05). All the analyses were done
in JMP 7.0 (SAS Institute).
Results
Overall population
A total of 8534 RHC procedures were performed in 5445 pa-
tients, at our institutionbetweenJanuary2002andDecember
2006. Five hundred and twenty six of these patients also
underwent NCS procedures, of which 230 had a resting
MPAP>25mmHg (Fig. 1) Twentyeight patientswereexcluded
since they had undergone cardiac surgeries prior to the listed
NCS chosen for data collection. After excluding an additional
45minor procedures and 61 duplicate PAC procedures, a total
of96caseswithPHremainedforanalysis.Themedian interval
betweenRHCandNCSwas269days. Similarly, after excluding
duplicate RHC procedures and cardiac surgeries a total of 77
controls were available for analysis. Of the 173 patients, 57%
were men, 56% had ASA class >2, and mean MPAP was
28.5  12.0 mmHg.
Comparison of patients with post-operative
complications with those without complications
Twenty seven patients encountered significant post-opera-
tive complications. Patient characteristics significantly as-
sociated with post-operative mortality and morbidity on
univariate analysis were diabetes mellitus (DM), obstructive
sleep apnea (OSA), chronic renal insufficiency (CRI), Amer-
ican Society of Anesthesiology (ASA) class, and surgical risk
class. Among hemodynamic characteristics, LVEF%, RVSP/
SBP,h MPAP, PCWP, PA pulse pressure, and PVR were signifi-
cantly associated with morbidity andmortality on univariate
analysis.
Comparison of PH vs non-PH groups (Tables 1e4)
Etiology of PH included PAH [NZ 12 (12.5%)], PVH [NZ 38
(39.5%)], and ‘mixed’ PH [N Z 46 (48%)]. Patients with PH
weremore likely to be female (pZ 0.04) and to have a higher
BMI (pZ 0.03), higher ASA class (pZ 0.01), DM (pZ 0.006),
OSA (p Z 0.01), and atrial fibrillation (p Z 0.01), and
a higher ASA class (.01) (Table 1). The surgical risk classes
were comparable between the two groups (p Z 0.35) and
most NCS procedures were intermediate risk (52% amongst
cases and 57% amongst controls) (Table 1). In contrast with
previous studies some high risk surgical procedures (Surgicalh Right ventricular systolic pressureeSystolic blood pressure
ratio.risk class 1) were also included (12.5% in patientswith PH and
6.5% among controls).
Of the 27 patients with significant perioperative com-
plications, 25 (92.5%) were in the PH group, including 1
death. The patient that died underwent an intermediate
risk NCS procedure, had MPAP > 45, and developed CHF
postoperatively.
Compared to controls, patients in the PH group were at
significantly higher risk of developing CHF (p < 0.001; OR:
11.9), HDI (p< 0.002), sepsis (p< 0.0005), and RF (p< 0.004)
(Table 2). A total of 13 patients (13%) developed post-opera-
tive CHF. Five among these needed hemodynamic monitoring
of which 2 needed dobutamine infusion, but eventually died
at 2 and 6 months respectively. Patients with PH were also
more likely to require longer ventilatory support (p < 0.002),
stay longer in the ICU (p < 0.04), and were more likely to be
readmitted to the hospital within 30 days of discharge (OR
2.4). Patients with PAH or ‘mixed’ PH had a much higher
likelihood ofdeveloping perioperative complications (41%and
24% respectively) when compared to patients with pure PVH
(16%) (Table 3) but these differences were not statistically
significant. In the multivariate model (Table 4), MPAP
(p Z 0.001), ASA class (p Z 0.02), and CRI (pZ 0.03) were
found to be independent risk factors for post-operative
morbidity and mortality.
Discussion
This is the first large, retrospective, cohort study of post-
operative outcomes in patients undergoing NCS with he-
modynamics accurately characterized by PAC. Our study
indicates that, in addition to traditional risk factors for
NCS like coronary artery disease, DM, CRI, and ASA class,
PH has a significant negative impact on post-operative
outcomes.
Table 1 Baseline characteristics of patients with and without pulmonary hypertension.
PH (n Z 96) No PH (n Z 77) P-values
Demographics
Age (Mean  SD) 62.4  11.5 59.6  12.0 .13
Sex (male)a 50 65.0 .048
Medical risk factors
BMI (Mean  SD) 31.0  8.9 28.2  5.4 .03
HTN 75.0 64.9 .15
DM 38.5 19.5 .006
CAD 44.8 52.0 .35
CHF 52.1 49.4 .72
Atrial fibrillation 32.3 15.6 .01
COPD 19.8 14.3 .34
PE 3.1 9.1 .09
DVT 9.4 11.7 .62
OSA 17.1 5.2 .01
CRI 30.2 31.2 .89
Surgical risk factors
ASA class (>2) 64.8 35.2 .01
Surgical risk class .35
1 12.5 6.2
2 52.1 59.7
3 35.4 33.8
Hemodynamics
Echocardiogram
LV EF % (Mean  SD) 45.9  15.8 48.3  14.8 .32
RVSP (Mean  SD) 49.4  20.6 36.4  10.7 <.0001
RSVP/SBP .38  .2 .29  .1 .002
Dilated RA 26.0 31.2 .46
PA cathetherization
MPAP (Mean  SD) 37.3  8.2 17.4  4.3 <.0001
PCWP mean 20.8  7.5 11.2  4.6 <.0001
Fick-CO 5.4  2.5 5.8  2.2 .39
PVR 3.3  2.1 1.2  .8 <.0001
BMI: Body Mass Index; HTN: Hypertension; DM: Diabetes Mellitus; CAD: Coronary Artery Disease; CHF: Congestive Heart Failure; COPD:
Chronic Obstructive Pulmonary Disease; OSA: Obstructive Sleep Apnea; PE: Pulmonary Embolism; DVT: Deep Venous Thrombosis; CRI:
Chronic Renal Insufficiency; ASA Class: American Society of Anesthesiology Class; LVEF: Left Ventricular Ejection Fraction; RVSP: Right
Ventricular Systolic Pressure; SBP: Systolic Blood Pressure; RA: Right Atrium; MPAP: Mean Pulmonary Arterial Pressure; PCWP: Pulmonary
Capillary Wedge Pressure; CO: Cardiac Output; PVR: Pulmonary Vascular Resistance.
a Numbers represent percentages within each group unless otherwise noted.
Table 2 Perioperative outcomes in patients with and without pulmonary hypertension after Non-cardiac surgery.
Perioperative Outcome PH (n Z 96) No PH (n Z 77) p-Value OR
Morbidity/Mortalitya 26.0 2.6 <.0001 13.1
Perioperative MI 1.0 .0 .28
Perioperative CHF 13.5 1.3 .001 11.9
Hemodynamic instability 8.3 0 .0020 e
Sepsis 10.4 0 .0005 e
Respiratory failure 7.3 0 .004 e
Prolonged intubation 8.3 0 .002 e
ICU length of stay (days) .66  2.7 .01  .11 .04 e
Hospital length of stay (days) 7.0  9.3 3.2  3.1 .0008 e
30 day hospital readmission 16.7 7.8 .08 2.4
MI Z Myocardial Infarction; CHF Z Congestive Heart Failure; ICU: Intensive Care Unit.
a Numbers represent percentages within each group unless otherwise noted.
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Table 3 Perioperative complications by pathophysiologic
category of PH.
Type of PH N Postop
morbidity
Postop
mortality
Pulmonary Arterial
Hypertensiona
12 5(41) 1(8)
Pulmonary Venous
Hypertensionb
38 6(16) e
Mixed Pulmonary
Hypertensionc
46 11(24) e
a (PCWP<15; PVR>3).
b (PCWP>15; PVR<3).
c (PCWP>15; PVR>3).
Pulmonary hypertensionIncidence of perioperative morbidity and mortality
in patients with underlying PH
We found lower perioperative mortality (approximately 1%)
and comparable perioperative morbidity (approximately
28%) compared to previous reports in patients with PH
undergoing NCS.11,12,20 Literature describing the perioper-
ative morbidity and mortality of patients with PH under-
going NCS is scarce.11e13 Ramakrishna et al reported a 7%
earlymortality and 42% short-termmorbidity in 145 patients
who underwent NCS. A major limitation of their study was
that it did not include a control group. In addition, PH was
predominantly characterized by echocardiographic criteria
(RVSP> 35 mmHg); and less than half (46%) of the cases had
angiographically proven PH.11 In a case series, Minai et al12
reported an increased incidence of post-operative compli-
cations in patients with PAHwho underwent intra-operative
PAC monitoring or were not on vasoactive therapy at the
time of surgery. These findings, though provocative, were
not statistically significant and require further investiga-
tion. More recently, Lai et al comparing 62 controls with an
equal number of cases presumed to have PH on the basis of
RVSP > 70 mmHg by Doppler echocardiography within 30
days, reported a 9.7% mortality and 24% morbidity after
NCS. The study reported no left or right heart catheteriza-
tion data, hence the contribution of left-sided cardiac
disease, if any, cannot be accurately assessed.20Table 4 Multiple logistic regression for morbidity and
morbidity in all patients. (Area under ROC curve: .85).
Variable ORa P-value
Age 1.04 .09
ASA class
(>2/ 2)
4.2 .02
Surgical
risk class
.06
2/1 1.7
3/1 5.8
CRI 3.2 .03
PH 15.3 .001
ASA Class: American Society of Anesthesiology Class; CRI:
Chronic.
Renal insufficiency; PH: Pulmonary Hypertension.
a OR (Yes/No).Significance of pulmonary hemodynamics in
predicting perioperative outcomes
Altered pulmonary hemodynamics and right ventricular dys-
function were significantly associated with perioperative out-
comes in our study. In the overall group,we also noted PA pulse
pressure (p Z 0.003) and PVR (.008) to be associated with
perioperative outcomes on univariate analysis. We believe that
this was partly the reason why the group with ‘mixed’ PH had
a higher complication rate. This finding is especially relevant
because recent reports have suggested that increased pulmo-
nary vascular stiffness, as measured by PA pulse pressure or
pulmonary vascular capacitance, may be an indicator of poor
outcomes in patients with PH.21,22
Ramakrishna et al.11 found preoperative RVSP/SBP> 0.66
to be an important predictor of short-term perioperative
mortality but not of short-termmorbidity. In our study, RVSP/
SBP was associated with perioperative morbidity on univar-
iate analysis (p < 0.02) whereas RVSP by itself was not
ststistically significant (p Z 0.06). RVSP/SBP was also
statistically significant (pZ 0.002), when included as a con-
tinous variable in our multivariate model, however, it was
excluded from the final analysis since the total number for
analysis decreased to 132.
We found CHF to be the single most frequent (>50%)
contributor to the post-operative morbidity and mortality.
Unlike previous reports, post-operative RF, was less frequent
however, this may have been masked by the concomitant
occurrence of CHF or sepsis which were considered as sepa-
rate categories for the purposes of our study. Patientswith PH
were more likely to stay in the intensive care unit post-
operatively and were also more likely to be readmitted to
the hospital within 30 days of discharge. These findings
have significant implications from the standpoint of patient
management. Perioperative complications were more com-
mon in patients with PAH compared to those with only PVH;
approximately 50% of patients with post-operative compli-
cations had ‘mixed’ PH (elevated PCWPand PVR). None of the
previous studies have attempted to address this issue
primarily because these studies did not have access to PAC
data among a majority of their patients. In that this finding
would tend to highlight the importance of PVR and right
ventricular function, it requires further investigation. Given
the low perioperative mortality in our group we could not
identify any risk factors for perioperative mortality.Study limitations
This study has the limitations of being a retrospective anal-
ysis and the typical institutional biases regarding patient
selection based on the experience of a single high surgical
volume institution. However, in contrast to other studies, it
provides valuable and accurate hemodynamic data based on
PAC.11,20 We used the available angiographic data within 2
years of the NCS selected for outcome analysis. Since at the
present time it is not mandated to do a preoperative RHC
prior to an NCS we could not overcome this limitation in
a retrospective analysis. In addition, we were unable to
obtain information regarding intra-operative factors influ-
encing the outcome including the use of intra-operative
nitrous oxide or vasopressors, intra-operative blood loss and
624 R. Kaw et al.type of anesthestic agents used. Any or all of these factors
may have had an impact on perioperative outcomes.
Conclusions
Our study highlights the fact that, in addition to traditional
risk factors for NCS such as coronary artery disease, DM, CHF,
CRI and ASA Class, the presence of underlying PH has
a significant negative impact on perioperative outcomes.
Compared to patients without PH, those with PH have
a higher incidence of CHF, RF, and HDI in addition to longer
ICU stay and higher 30 day readmission rates. Prospective
studies are needed to better evaluate the true significance of
PH on perioperative outcomes in patients undergoing NCS.
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